Archive

Category: Explore

Synaffix Expands its Existing Collaboration with ADC Therapeutics to Explore Two Additional Programs

Shots: Synaffix to receive upfront, milestone and royalty payments tied to each program while ADC gets a non-exclusive right for two additional programs, bringing the total number of programs to five ADC also get access to Synaffix’ GlycoConnect platform, including DAR1 technology enabling stable attachment of just a single drug per antibody In 2016, the […]

NCCN Collaborates with Pfizer to Explore Adoption of Biosimilars in Oncology

Shots: NCCN and Pfizer have issued an open RFP that develop and validate enduring approaches to improve the safe, effective, and efficient adoption of biosimilars in oncology The RFP supports approaches to improve the processes related to biosimilar adoption in oncology. Letters of Intent are welcome from academic or community centers, patient advocacy groups and […]